Navigation Links
Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting
Date:6/17/2011

expects to file the NDA for avanafil in the second quarter of 2011.

About AvanafilAvanafil is an investigational oral medication being developed for the treatment of erectile dysfunction.  Avanafil is a highly selective phosphodiesterase type 5 (PDE5) inhibitor licensed from Mitsubishi Tanabe Pharma Corporation. With the exception of certain Asian Pacific Rim countries, VIVUS owns worldwide development and commercial rights to avanafil for the treatment of sexual dysfunction.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by U.S. and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial QNEXA NDA on October 28, 2010. QNEXA is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has completed phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "estimate," "expect," "forecast" and "intend," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the timing and substance of our response to the FDA's requests from the QNEXA End-of-Review meeting; our response to, and continued dialogue with, the F
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
2. Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil
3. BioSpecifics Announces Positive XIAPEX® Data Presented at XVI Annual Federation of European Societies for Surgery of the Hand Congress
4. Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients
5. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
6. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
7. KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain
8. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
9. Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting
10. Positive Results Reported for Phase II Randomized Double-Blind Clinical Trial for the Treatment of Drug-Resistant Epilepsy Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
11. Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/ljsxt8/asia_pacific ) has ... Ray Devices Market - Growth, Trends And Forecasts (2014 - ... Asia Pacific market for Portable X-Ray ... 2014 to 2020 X-Ray is a form of ... the body, especially bones. The need of point of care ...
(Date:5/27/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ) has ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... is a detailed type of imaging that customs a ... called a mammogram, is used to support in the ... An x-ray (radiograph) is a noninvasive medical test that ...
(Date:5/27/2015)... senior marketing associate with the animal health division of Eli Lilly and ... setting in Bangkok, Thailand , will be among the ... respect and dignity is the guiding star for me and my fellow ... LillyPad blog . Donatelli and Lilly colleagues from ... , France , Ukraine ...
Breaking Medicine Technology:Asia Pacific Portable X Ray Devices Market 2015 - Trends And Forecasts to 2019 2Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3
(Date:5/27/2015)... Hills, CA (PRWEB) May 27, 2015 Khanna ... of the art web portal focussed on keratoconus eye ... This relentless progressive disease has its onset in the teenage ... down. The cornea or the front clear part of the ... the pressure in the eye. It results in poor vision ...
(Date:5/27/2015)... New York, New York (PRWEB) May 27, 2015 ... http://www.risperdallawsuit2014.com/ ) filed on behalf of individuals ... other complications related to the use of the ... mass tort litigation currently underway in Pennsylvania’s Philadelphia ... the litigation is proceeding with its bellwether trial ...
(Date:5/27/2015)... 27, 2015 In today's healthcare landscape, ... it can be challenging for doctors and hospitals to ... treatments. , Austin-based HealthTronics, Inc. is ... mobile medical therapies for clinically sophisticated applications. The company ... acquisition of Laser Ventures, Inc ., a mobile ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), ... enterprise organizations, announced today that SanMar Corporation successfully ... time, attendance and point tracking processes for over ... States. , Family-owned since 1971, Seattle-based SanMar ... private label, and mill brands. SanMar supplies apparel ...
(Date:5/27/2015)... Little Rock, AR (PRWEB) May 27, 2015 ... and Medix today announce a partnership to provide ... the Medix community. This collaboration seeks to strengthen ... skills measurement through CMSA’s CKP program. The mutually ... focused on identifying individual skills of talent in ...
Breaking Medicine News(10 mins):Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3
... PHOENIX, Jan. 10 NutraCea (OTC Bulletin,Board: ... bran (SRB), nutrient,research and technology, announced today ... HerbalScience Singapore Ltd Pte, a company that ... nutraceutical uses,and identifies novel chemistries for drug ...
... Inc. (AIM: TYR), the,pioneer of safer, effective ... achieved development and financial milestones from Arysta,LifeScience ... exclusive global,licensing and co-development agreement to manufacture ... certain horticultural markets., TyraTech is developing ...
... Plan of Care Module (ePOC) to Drive ... Enhanced Physician Customer Satisfaction, BERKELEY HEIGHTS, N.J., ... worldwide provider of secure workflow,management software and web-based services, today ... care organization, is,extending its use of the Inscrybe Healthcare platform ...
... VALLEY, Calif., Jan. 9 Synergy Life Science,Partners, ... investments,in emerging medical device technologies, today announced the ... an aggregate of $143,million in committed capital. The ... Founded in 2006 by John Onopchenko, Richard Stack, ...
... Her Battle ... with Hepatitis C, NEW YORK, Jan. ... advocating on behalf of,Americans with liver disease, is proud announce that it ... disease,including hepatitis C. To help spread the word about ALF,s work, EHE ...
... drugs are unregulated and could be dangerous, agency ... U.S. health officials warned Wednesday about so called ... popular alternative therapy among women with menopausal symptoms. ... said they,ve sent warning letters to seven pharmacies, ...
Cached Medicine News:Health News:NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran 2Health News:NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran 3Health News:NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran 4Health News:TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience 2Health News:TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience 3Health News:Advanced Home Care Extends Its Use of Authentidate's Inscrybe(TM) Healthcare Platform 2Health News:Advanced Home Care Extends Its Use of Authentidate's Inscrybe(TM) Healthcare Platform 3Health News:Advanced Home Care Extends Its Use of Authentidate's Inscrybe(TM) Healthcare Platform 4Health News:Synergy Life Science Partners Closes $143M Debut Medical Device Fund 2Health News:Synergy Life Science Partners Closes $143M Debut Medical Device Fund 3Health News:EHE International Supports the American Liver Foundation's Efforts at Raising Awareness for Hepatitis 2Health News:FDA Warns Against Bio-Identical Hormone Therapy 2Health News:FDA Warns Against Bio-Identical Hormone Therapy 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: